Entropy Technologies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
13,311
-5,200
-28% -$1.08M 0.13% 239
2026
Q1
$3.91M Buy
+18,511
New +$3.99M 0.18% 153
2025
Q3
Sell
-37,215
Closed -$6.25M 841
2025
Q2
$6.25M Buy
37,215
+19,386
+109% +$2.88M 0.5% 44
2025
Q1
$2.46M Buy
17,829
+4,334
+32% +$552K 0.24% 118
2024
Q4
$1.6M Buy
+13,495
New +$1.58M 0.16% 187
2024
Q2
Sell
-8,197
Closed -$917K 694
2024
Q1
$917K Buy
+8,197
New +$884K 0.1% 306

Other funds holding CAH

Entropy Technologies's CAH Position: Q2 2026 in Review

Entropy Technologies reduced its Cardinal Health (CAH) stake by 28% in Q2 2026, selling an estimated $1.08M and leaving 13,311 shares worth $3.16M. The position accounts for 0.13% of the portfolio, ranked #239.

Entropy Technologies first reported a position in CAH in Q1 2024 and has held it in 6 quarters since. The position peaked at $6.25M in Q2 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Entropy Technologies held 13,311 shares of Cardinal Health worth $3.16M as of Q2 2026.
  • Entropy Technologies sold 5,200 Cardinal Health shares in Q2 2026, an estimated $1.08M.
  • Cardinal Health made up 0.13% of Entropy Technologies's portfolio in Q2 2026, its #239 holding.
  • Entropy Technologies first reported a position in Cardinal Health in Q1 2024 and has held it in 6 quarters since.
  • Entropy Technologies's Cardinal Health position peaked at $6.25M in Q2 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.